Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors

Launched by APOLLO MEDICAL OPTICS, LTD · Oct 2, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technology called high-resolution optical coherence tomography (OCT) to help doctors better diagnose skin tumors, including both cancerous and non-cancerous lesions. This method allows for detailed 3D pictures of the skin, which can help reduce the need for unnecessary biopsies—procedures where a small piece of skin is removed to check for cancer. The goal is to see if this technology can improve the accuracy of skin cancer diagnosis, ultimately helping patients get the right treatment more quickly.

To participate in the trial, you must be over 18 years old and have a skin lesion that doctors suspect may be cancerous or that needs to be removed for other reasons. If you join the study, you will undergo a non-invasive assessment using the new imaging technology, as well as other established methods. It’s important to know that those with certain medical conditions or who are under 18 are not eligible to participate. This trial is currently recruiting participants, and it aims to improve how skin tumors are diagnosed, which could lead to better outcomes for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged \> 18 years
• • Willingness to participate in this study including the assessment with high resolution OCT
• • Skin lesion/tumor with suspicion for skin cancer that requires skin biopsy or complete excision
• • Benign skin tumor that is scheduled for excision due to suspicion, irritation or for cosmetic reason
• Exclusion Criteria:
• • Patients aged \< 18 years
• • Any unstable medical or psychological conditions
• • Unwillingness to participate in this study including the assessment with high resolution OCT